Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Compass Therapeutics
CMPX
$349M
| $4.7M | ﹤0.01% |
+1,472,611
| New | +$4.88M |
|
1077
QuidelOrtho
QDEL
$1.13B
| $4.69M | ﹤0.01% |
34,773
-378,219
| -92% | -$52.6M |
|
|
ISBC
1078
DELISTED
Investors Bancorp, Inc.
ISBC
| $4.68M | ﹤0.01% |
308,774
+74,796
| +32% | +$1.15M |
|
1079
Oneok
OKE
$56.7B
| $4.66M | ﹤0.01% |
79,319
-353,487
| -82% | -$21.9M |
|
1080
Liberty Broadband Class C
LBRDK
$4.89B
| $4.64M | ﹤0.01% |
28,785
-2,320
| -7% | -$382K |
|
1081
TTEC Holdings
TTEC
$124M
| $4.64M | ﹤0.01% |
51,208
+5,645
| +12% | +$512K |
|
1082
International Paper
IP
$22.6B
| $4.61M | ﹤0.01% |
98,207
-1,547,085
| -94% | -$76.3M |
|
|
ZNGA
1083
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $4.59M | ﹤0.01% |
716,989
-969,928
| -57% | -$6.69M |
|
1084
Cleveland-Cliffs
CLF
$6.49B
| $4.58M | ﹤0.01% |
210,330
+162,536
| +340% | +$3.5M |
|
1085
Concentrix
CNXC
$1.62B
| $4.54M | ﹤0.01% |
25,381
+4,545
| +22% | +$811K |
|
1086
CGI
GIB
$15.4B
| $4.53M | ﹤0.01% |
51,175
+11,620
| +29% | +$1.02M |
|
1087
Keurig Dr Pepper
KDP
$42.8B
| $4.52M | ﹤0.01% |
122,609
-852,612
| -87% | -$30.1M |
|
1088
Zillow
ZG
$7.85B
| $4.51M | ﹤0.01% |
72,542
-93,625
| -56% | -$6.72M |
|
1089
Denali Therapeutics
DNLI
$3.79B
| $4.48M | ﹤0.01% |
100,463
+92,593
| +1,177% | +$4.39M |
|
|
AMED
1090
DELISTED
Amedisys
AMED
| $4.46M | ﹤0.01% |
27,575
+835
| +3% | +$134K |
|
1091
Palantir
PLTR
$295B
| $4.46M | ﹤0.01% |
244,717
-17,166
| -7% | -$379K |
|
1092
First Industrial Realty Trust
FR
$8.66B
| $4.46M | ﹤0.01% |
67,298
+54,264
| +416% | +$3.27M |
|
|
JNPR
1093
DELISTED
Juniper Networks
JNPR
| $4.43M | ﹤0.01% |
123,998
-77,796
| -39% | -$2.43M |
|
|
SPLK
1094
DELISTED
Splunk Inc
SPLK
| $4.42M | ﹤0.01% |
38,213
-33,624
| -47% | -$4.7M |
|
1095
Fortis
FTS
$29.3B
| $4.39M | ﹤0.01% |
90,876
-7,800
| -8% | -$353K |
|
1096
Coca-Cola Europacific Partners
CCEP
$49.1B
| $4.34M | ﹤0.01% |
77,676
-14,935
| -16% | -$805K |
|
1097
NiSource
NI
$21.5B
| $4.34M | ﹤0.01% |
157,102
-621,179
| -80% | -$15.8M |
|
1098
Fulgent Genetics
FLGT
$558M
| $4.3M | ﹤0.01% |
42,777
+3,075
| +8% | +$270K |
|
1099
Vanguard FTSE Pacific ETF
VPL
$7.77B
| $4.3M | ﹤0.01% |
55,098
+23,519
| +74% | +$1.88M |
|
1100
Franklin Resources
BEN
$16.8B
| $4.29M | ﹤0.01% |
127,977
-75,175
| -37% | -$2.47M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.